Biotechnology Companies in Emerging Markets (China, Singapore, Brazil, South Africa, South Korea, Turkey, India, Russia)
Published Aug 17, 2015 | 36 Pages | Pub ID: KLI5668767
What’s happening in biotechnology in the fastest-growing economies of the world? Who are the leaders operating in these nations and what partnerships have they completed? This report provides answers and informs readers of the companies they need to know about. Companies seeking new partners, companies to invest in or firms benchmarking competition will want to purchase this resource of today’s biotech market in the countries outside the United States and Europe.
The report identifies eight important emerging company markets and details the biotech market size in these markets. Biotechnology is one of the fastest-growing segments of the world economy. By the year 2025 it has been estimated that the world biotechnology market will reach $2 trillion. By developing biotech, countries lay the groundwork for their own long-term economic growth.
In recent years, investment in U.S. biotech research has been reduced by billions of dollars while at the same time investment in such research in emerging markets has dramatically increased. As a result of this investment, many of these emerging market countries have put in place formal strategies to capitalize on the opportunities such expenditures represent.
This Kalorama Information report, Biotechnology Companies in Emerging Markets, examines the biotech market and notes companies in this market in the following countries:
- South Africa
- South Korea
Not only is the competition in each market assessed, but significant deals with major global concerns and among companies are detailed. The information presented in this report is the result of data gathered from government reports, company product literature